Detalhe da pesquisa
1.
Oncogenic lncRNA downregulates cancer cell antigen presentation and intrinsic tumor suppression.
Nat Immunol
; 20(7): 835-851, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31160797
2.
Mechanisms Controlling PD-L1 Expression in Cancer.
Mol Cell
; 76(3): 359-370, 2019 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31668929
3.
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1.
Mol Cell
; 71(4): 606-620.e7, 2018 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30118680
4.
Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer.
J Biol Chem
; 298(4): 101817, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35278434
5.
Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma.
J Hepatol
; 74(4): 907-918, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33031845
6.
Erratum to 'Ribonuclease 7-driven activation of ROS1 is a potential therapeutic target in hepatocellular carcinoma' [J Hepatol 2021 (907-918)].
J Hepatol
; 77(2): 580, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35489965
7.
Thymosin beta-4 knockdown in IEC-6 normal intestinal epithelial cells induces DNA re-replication via downregulating Emi1.
J Cell Physiol
; 229(11): 1639-46, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24615569
8.
Reshaping the Tumor Microenvironment of KRASG12D Pancreatic Ductal Adenocarcinoma with combined SOS1 and MEK Inhibition for Improved Immunotherapy Response.
Cancer Res Commun
; 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38727236
9.
Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation.
Int J Biol Sci
; 19(10): 2957-2973, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37416781
10.
Inhibition of Galectin-9 sensitizes tumors to anthracycline treatment via inducing antitumor immunity.
Int J Biol Sci
; 19(14): 4644-4656, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37781042
11.
Nuclear export signal mutation of epidermal growth factor receptor enhances malignant phenotypes of cancer cells.
Am J Cancer Res
; 13(4): 1209-1239, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37168336
12.
Phosphorylation and Stabilization of PD-L1 by CK2 Suppresses Dendritic Cell Function.
Cancer Res
; 82(11): 2185-2195, 2022 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35385574
13.
Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex.
Nat Cancer
; 3(10): 1211-1227, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36253486
14.
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer.
Sci Immunol
; 7(72): eabl9330, 2022 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35687697
15.
TYRO3 induces anti-PD-1/PD-L1 therapy resistance by limiting innate immunity and tumoral ferroptosis.
J Clin Invest
; 131(8)2021 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33855973
16.
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation.
Nat Commun
; 12(1): 2788, 2021 05 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33986289
17.
New Approaches on Cancer Immunotherapy.
Cold Spring Harb Perspect Med
; 10(8)2020 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31615865
18.
Erratum: The stabilization of PD-L1 by the endoplasmic reticulum stress protein GRP78 in triple-negative breast cancer.
Am J Cancer Res
; 10(10): 3507, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33163286
19.
The stabilization of PD-L1 by the endoplasmic reticulum stress protein GRP78 in triple-negative breast cancer.
Am J Cancer Res
; 10(8): 2621-2634, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32905506
20.
Inhibition of c-MET upregulates PD-L1 expression in lung adenocarcinoma.
Am J Cancer Res
; 10(2): 564-571, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32195027